Please login to the form below

Not currently logged in
Email:
Password:

regenerative medicine

This page shows the latest regenerative medicine news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

collaborations and licensing deals with academic and industrial partners, which now number 55 across “immuno-oncology, gene editing and regenerative medicine.”.

Latest news

More from news
Approximately 2 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    Now moving into its next phase of implementation, the vision is to make a genomics medicine service a reality in the UK – which will be a first anywhere in the world. ... An exceptional scientist-entrepreneur, Hackett trained initially in regenerative

  • Health on instalment Health on instalment

    Express Scripts stands ready to do its part.”. Or as the Alliance for Regenerative Medicine’s co founder Michael Werner put it: “When you’ve got products that demonstrate the kind

  • A unique ecosystem A unique ecosystem

    Regenerative medicine aims to repair injuries or diseased organs using biomaterials, gene therapy, cell therapy and tissue engineering. ... It has an almost unlimited growth potential. The global market for regenerative medicine is estimated to reach

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    Commenters, including the Regenerative Medicine Experts Group in the UK, have suggested that the current Health Technology Assessment (HTA) methodologies, such as the National Institute for Health and Care Excellence (NICE), ... The NICE appraisal

  • Deal Watch July 2016 Deal Watch July 2016

    a privately held regenerative medicine company. ... Acquisition. 80. BioD/ Derma Sciences. Regenerative medicine productions derived from placental &birth tissues for multiple indications.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Emotive grows medical writing capacity Emotive grows medical writing capacity

    Prior to this she worked at the Swiss Institute for Regenerative Medicine as its project manager and scientific medical writer.

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Forte’s expertise is predominantly in regenerative medicine, cell therapy, medical and regulatory affairs industries and is currently chief commercialisation officer and chair of the commercialisation committee for the International Society

  • Avita Medical appoints CEO Avita Medical appoints CEO

    Perry has been a non-executive director for the Cambridge, UK-based regenerative medicine firm since February 2013 and previously served at Novartis in roles such as senior vice president and

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    Bravo has over 25 years of experience in the biopharmaceutical industry, and is a member of the executive committee of the Alliance for Regenerative Medicine (ARM).

  • Liberation Unlimited promotes Danielle Smith Liberation Unlimited promotes Danielle Smith

    She has a BSc in Cellular and Molecular Medicine, specialising in cancer mechanisms, developmental genetics, embryonal cancers, medical virology and regenerative medicine.

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics